124 related articles for article (PubMed ID: 2431695)
1. Pharmacology of the anticholinergic bronchospasmolytic agent flutropium bromide.
Bauer R; Fügner A
Arzneimittelforschung; 1986 Sep; 36(9):1348-52. PubMed ID: 2431695
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacology of the bronchospasmolytic oxitropium bromide].
Bauer VR
Arzneimittelforschung; 1985; 35(1A):435-40. PubMed ID: 4039183
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of the bronchospasmolytic agent flutropium bromide and of some homologous and configuration isomeric compounds.
Banholzer R; Pook KH; Stiasni M
Arzneimittelforschung; 1986 Aug; 36(8):1161-6. PubMed ID: 3778552
[TBL] [Abstract][Full Text] [Related]
4. [General pharmacology and secretion inhibitory action of (8r)-3alpha-hydroxy-8-isopropyl-1alphaH,5alphaH-tropanium bromide-(+/-)-tropate (ipratropiumbromide) (author's transl)].
Bauer R; Kuhn FJ; Stockhaus K; Wick H
Arzneimittelforschung; 1976; 26(5a):974-80. PubMed ID: 134727
[TBL] [Abstract][Full Text] [Related]
5. Molecular and crystal structure of flutropium bromide.
Kiel G
Arzneimittelforschung; 1986 Aug; 36(8):1166-8. PubMed ID: 3778553
[TBL] [Abstract][Full Text] [Related]
6. [Effects of flutropium bromide, a new antiasthma drug, on mediator release from mast cells and actions of mediators].
Misawa M; Yanaura S; Hosokawa T; Mizuno H; Irinoda K; Takahashi Y; Yoshimura K; Maruyama Y; Sugimoto K; Ohno H
Nihon Yakurigaku Zasshi; 1988 Feb; 91(2):97-103. PubMed ID: 2453423
[TBL] [Abstract][Full Text] [Related]
7. Effect of ipratropium bromide on the action of bronchoactive agents.
Kitamura S; Ishihara Y; Sugiyama Y; Izumi T; Hayashi R; Hsu LH; Kosaka K
Arzneimittelforschung; 1982; 32(2):128-30. PubMed ID: 6461333
[TBL] [Abstract][Full Text] [Related]
8. Methyl atropine bromide versus atropine sulphate. A clinical comparison.
Rupreht J; Stienstra R; Dworacek B; Eggels PJ
Acta Anaesthesiol Belg; 1983 Dec; 34(4):301-7. PubMed ID: 6369862
[TBL] [Abstract][Full Text] [Related]
9. Urinary bladder-selective action of the new antimuscarinic compound vamicamide.
Oyasu H; Yamamoto T; Sato N; Sawada T; Ozaki R; Mukai T; Ozaki T; Nishii M; Sato H; Fujiwara T
Arzneimittelforschung; 1994 Nov; 44(11):1242-9. PubMed ID: 7848339
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 1: Antimuscarinic and spasmolytic effects.
Zwagemakers JM; Claassen V
Arzneimittelforschung; 1980; 30(9):1517-26. PubMed ID: 7193020
[TBL] [Abstract][Full Text] [Related]
11. Atropine methylbromide and glycopyrrolate. A comparative study during reversal of neuromuscular block.
Dworacek B; Rupreht J; Bode A; Walhout MJ
Acta Anaesthesiol Belg; 1987; 38(2):147-52. PubMed ID: 3661106
[TBL] [Abstract][Full Text] [Related]
12. Effects of muscarinic antagonists on experimental nasal secretion in guinea pigs.
Mizuno H; Iwase N; Kawamura Y; Ohno H; Hosokawa T; Kasuya Y
Jpn J Pharmacol; 1991 Apr; 55(4):531-7. PubMed ID: 1886292
[TBL] [Abstract][Full Text] [Related]
13. Bronchospasmolytic effects of methscopolamine bromide.
Wasserman MA; Griffin RL
J Pharmacol Exp Ther; 1979 Oct; 211(1):159-66. PubMed ID: 490316
[No Abstract] [Full Text] [Related]
14. [Anticholinergic properties of oxitropium bromide (Ba 253) and its metabolites].
Kitagawa H; Takeda F; Izumita M; Hayashi T; Kohei H
Nihon Yakurigaku Zasshi; 1989 Feb; 93(2):49-54. PubMed ID: 2524433
[TBL] [Abstract][Full Text] [Related]
15. [Effects of flutropium bromide, a new antiasthma drug, with repeated administration on bronchomotor response and hepatic drug metabolizing enzymes].
Mizuno H; Kawabata N; Ohno H; Misawa M
Nihon Yakurigaku Zasshi; 1989 Jun; 93(6):333-40. PubMed ID: 2567689
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the systemic anticholinergic activity of nasally administered ipratropium bromide.
Laurikainen E; Koulu M; Kaila T; Scheinin M; Isalo E
Rhinology; 1988 Jun; 26(2):133-8. PubMed ID: 2972054
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology and toxicology of Atrovent.
Engelhardt A
Scand J Respir Dis Suppl; 1979; 103():110-5. PubMed ID: 155286
[TBL] [Abstract][Full Text] [Related]
18. [Hemodynamic effects in antagonism of neuromuscular blockage: atropine-pyridostigmine versus ipratropium bromide-pyridostigmine].
Stoyanov M; Müller H; Lobisch M; Hempelmann G
Anaesthesist; 1984 Oct; 33(10):499-503. PubMed ID: 6239562
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology and toxicology of ipratropium bromide.
Cugell DW
Am J Med; 1986 Nov; 81(5A):18-22. PubMed ID: 2947457
[TBL] [Abstract][Full Text] [Related]
20. [Effect of ipratropium bromide (Sch 1000) on the action of various bronchoactive agents (author's transl)].
Ishihara Y; Izumi T; Hayashi R; Hsu LH; Sugiyama Y; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Aug; 18(8):501-5. PubMed ID: 6448308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
